ITC ALJ Finds Jawbone’s Health- and Sleep-Monitoring Patents Directed to Ineligible Subject Matter

May 6, 2016

Reading Time : 2 min

First, ALJ Lord found both patents directed to the abstract ideas of collecting and monitoring sleep and other health-related data. The ’413 patent claims a “system for monitoring and reporting a human status parameter of an individual” comprising a housing that includes two sensors for generating physiological data, a processor for calculating sleep onset and wake information, and a transceiver to output said information. Similarly, the ’707 patent claims a “system for detecting, monitoring, and reporting a status of an individual to a user” that comprises two sensors for generating physiological data, a processor, a monitoring unit and an output device, wherein the processor or monitoring unit processes the data collected by the sensors and outputs information regarding the processed data.

With respect to the ’413 patent, ALJ Lord found that monitoring sleep patterns is an abstract idea that has been practiced for centuries and can be carried out in the human brain. Jawbone did not invent any of the means for monitoring sleep recited in the patent; rather it used well- known, existing sensors to collect sleep data in a conventional manner. The physical components of the system, such as the sensors, do not rescue the claims from ineligibility because they are not new and only limit the invention to a particular field of use or technological environment.

Moving to step two of the Mayo test, ALJ Lord found that neither patent claimed an innovative concept sufficient to transform the claimed abstract idea into patent-eligible subject matter, as they both used only generic computer hardware used in conventional fashion to collect and organize human activity that was previously performed by human beings. A computer’s improvement in monitoring speed and accuracy does not provide a sufficient inventive concept because this is merely what computers do. All of the claimed hardware is generic, and Jawbone did not invent any of the processors, sensors or transceivers that are in the system, or use any of the components in new or unexpected ways.

ALJ Lord found the claims of the ’707 patent ineligible for reasons similar to those for the ’413 patent. The ’707 patent claims the abstract idea of collecting information about an individual’s health status and presenting that information to an individual. Doctors and nurses routinely perform this type of data collection and data output using pen and paper, and nothing in the claims transforms the quality of the collected data. Also, the ’707 patent does not describe any technological advance and relies purely on conventional electronic devices.

In the Matter of Certain Activity Tracking Devices, Systems, and Components Thereof, Inv. No. 337-TA-963, Order No. 54 (April 27, 2016 ITC).

Share This Insight

Previous Entries

IP Newsflash

March 24, 2025

The Federal Circuit affirmed a Patent Trial and Appeal Board (PTAB) final written decision holding that the prior art exception of AIA Section 102(b)(2)(B) does not apply to a prior sale by an inventor when the sale is conducted in private. According to the Federal Circuit, a sale must disclose the relevant aspects of the invention to the public to qualify for the prior art exception of Section 102(b)(2)(B).

...

Read More

IP Newsflash

March 21, 2025

Under the Lanham Act, a plaintiff who prevails on a trademark infringement claim may be entitled to recover the “defendant’s profits” as damages. The Supreme Court in Dewberry Group, Inc. v. Dewberry Engineers Inc. unanimously construed “defendant’s profits” in 35 USC § 1117(a) to mean that only the named defendant’s profits can be awarded, not the profits of other related corporate entities. The Court, however, left open the possibility that other language in § 1117(a) may allow for damages linked to the profits of related entities, if properly raised and supported.

...

Read More

IP Newsflash

March 13, 2025

In a series of rulings on a motion in limine, the District of Delaware recently distinguished between what qualifies as being incorporated by reference and what does not for the purposes of an anticipation defense. In short, a parenthetical citation was held to be insufficient, while three passages discussing a cited reference met the test.

...

Read More

IP Newsflash

March 4, 2025

On February 28, 2025, the USPTO announced that it was rescinding former Director Vidal’s 2022 memorandum on discretionary denials by the Patent Trial and Appeal Board. The 2022 memorandum effectively narrowed the application of discretionary denials in cases with parallel district court litigation by specifying instances where discretionary denial could not be issued. With the withdrawal of the memorandum, individual PTAB panels will regain flexibility in weighing discretionary denials. While the long-term effect of that increased flexibility is not yet known, the immediate effect is likely to be a shift towards the discretionary analysis applied by PTAB panels before the issuance of the memorandum.

...

Read More

IP Newsflash

March 3, 2025

A District of Delaware judge recently granted a defendant’s motion to include a patent prosecution bar in its proposed protective order after determining that litigation counsel’s ability to practice before the Patent Office—without ever having represented the plaintiffs at the Patent Office in the past—weighed heavily in favor of the bar.

...

Read More

IP Newsflash

February 12, 2025

The Federal Circuit recently reversed a district court decision that found a patent that did not describe after-arising technology failed to satisfy the written description requirement. In so doing, the Federal Circuit explained that written description and enablement are evaluated based on the subject matter that is claimed, not the products that practice those claims. As a result, the patentee was not required to describe unclaimed, later-discovered features of the accused products despite the broad language in the claims that undisputedly covered the products.

...

Read More

IP Newsflash

January 24, 2025

The District of Delaware recently rejected a patentee’s argument that non-production of an opinion letter from counsel, combined with knowledge of the patent, warranted a finding that defendant induced infringement.

...

Read More

IP Newsflash

January 17, 2025

The District of Delaware recently denied a motion to dismiss a patent infringement complaint involving gene editing technology that sought relief under the Safe Harbor Provision of the Hatch-Waxman Act. Specifically, the court found the patentee’s complaint sufficiently alleged at least some uses of the claimed technology that, when taken as true, were not solely uses of a “patented invention” that were “reasonably related” to an FDA submission.

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.